A Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic Cardiomyopathy

PHASE2RecruitingINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

July 4, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions

Hypertrophic Cardiomyopathy

Interventions

DRUG

HRS-1893 Tablet

HRS-1893 tablet.

Trial Locations (1)

RECRUITING

Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing

All Listed Sponsors

lead

Shandong Suncadia Medicine Co., Ltd.

INDUSTRY